https://cureangelman.org/news/fast-announces-establishment-of-associated-drug-development-accelerator-as%c2%b2bio/ 2024-06-04T00:00:00+00:00 https://cureangelman.org/news/2024-global-science-summit-recap/ 2024-11-20T00:00:00+00:00 https://cureangelman.org/news/fast-and-asf-announce-their-partnership-with-the-institute-for-gene-therapies/ 2024-12-06T00:00:00+00:00 https://cureangelman.org/news/rsvp-for-the-january-2025-el-pfdd-meeting/ 2024-12-06T00:00:00+00:00 https://cureangelman.org/news/fast-and-asf-advocate-for-crucial-legislation/ 2024-12-11T00:00:00+00:00 https://cureangelman.org/news/ultragenyx-announces-first-patients-dosed-in-pivotal-phase-3-aspire-study-evaluating-gtx-102-in-angelman-syndrome/ 2024-12-19T00:00:00+00:00 https://cureangelman.org/news/can-community-spotlight-joelene/ 2025-01-22T00:00:00+00:00 https://cureangelman.org/news/introducing-the-innovation-seed-grant-supporting-early-stage-angelman-syndrome-research/ 2025-01-22T00:00:00+00:00 https://cureangelman.org/news/fast-affiliated-research-program-at-ucla-is-awarded-5-8m-to-advance-gene-therapy-for-angelman-syndrome/ 2025-01-30T00:00:00+00:00 https://cureangelman.org/news/international-angelman-day-2025-round-up/ 2025-02-19T00:00:00+00:00 https://cureangelman.org/news/a-high-sensitivity-assay-of-ube3a-ubiquitin-ligase-activity-from-dr-albert-keungs-lab/ 2025-02-19T00:00:00+00:00 https://cureangelman.org/news/the-economic-burden-of-caring-for-individuals-with-angelman-syndrome/ 2025-03-18T00:00:00+00:00 https://cureangelman.org/news/exciting-announcement-launch-of-our-new-electronic-journal/ 2025-03-31T00:00:00+00:00 https://cureangelman.org/news/ionis-reveal-phase-3-clinical-trial-update/ 2025-04-08T00:00:00+00:00 https://cureangelman.org/news/fast-funded-researcher-highlights-the-involvement-of-ube3a-in-different-neurodegenerative-diseases/ 2025-04-14T00:00:00+00:00 https://cureangelman.org/news/expanding-the-pre-clinical-research-landscape-for-angelman-syndrome/ 2025-04-29T00:00:00+00:00 https://cureangelman.org/news/more-than-a-seat-at-the-table-fasts-role-in-shaping-the-future-of-angelman-syndrome-at-asgct-2025/ 2025-05-29T00:00:00+00:00 https://cureangelman.org/news/fast-announces-funding-for-first-innovative-seed-grant/ 2025-06-09T00:00:00+00:00 https://cureangelman.org/news/leading-neurology-and-rare-disease-expert-dr-nick-france-joins-fast-board/ 2025-06-09T00:00:00+00:00 https://cureangelman.org/news/investing-in-the-future-of-angelman-syndrome-research-fast-partners-with-asgct-to-support-early-career-scientists/ 2025-06-12T00:00:00+00:00 https://cureangelman.org/news/ultragenyx-receives-breakthrough-therapy-designation-for-gtx-102-in-angelman-syndrome/ 2025-06-27T00:00:00+00:00 https://cureangelman.org/news/oak-hill-bio-announces-publication-of-rugonersen-phase-1-study-results-in-nature-medicine/ 2025-07-11T00:00:00+00:00 https://cureangelman.org/news/inside-insync-as-2025-progress-partnership-and-possibilities-for-angelman-syndrome/ 2025-07-24T00:00:00+00:00 https://cureangelman.org/news/ultragenyx-completes-enrollment-of-phase-3-aspire-study-evaluating-gtx-102-for-the-treatment-of-angelman-syndrome/ 2025-07-31T00:00:00+00:00 https://cureangelman.org/news/fast-funded-project-introduces-first-large-animal-model-to-study-angelman-syndrome/ 2025-09-05T00:00:00+00:00 https://cureangelman.org/news/ionis-receives-breakthrough-therapy-designation-for-ion582-in-angelman-syndrome/ 2025-09-09T00:00:00+00:00 https://cureangelman.org/news/reading-the-brains-signals-to-speed-better-treatments-for-angelman-syndrome/ 2025-09-19T00:00:00+00:00 https://cureangelman.org/news/mavrix-bio-mvx-220-update/ 2025-09-22T00:00:00+00:00 https://cureangelman.org/news/fast-x-asa-angelman-syndrome-clinical-trials-webinar-europe-uk-sites-eligibility-and-how-to-join-trials/ 2025-10-16T00:00:00+00:00 https://cureangelman.org/news/voice-of-the-patient-report-submitted-a-powerful-milestone-for-the-angelman-syndrome-community/ 2025-11-03T00:00:00+00:00 https://cureangelman.org/news/as-natural-history-study-celebrates-20-years/ 2026-02-19T00:00:00+00:00 https://cureangelman.org/news/fast-leaders-to-speak-at-the-cnbc-cures-summit-on-patient-and-family-led-advocacy/ 2026-02-20T00:00:00+00:00 https://cureangelman.org/news/international-angelman-day-2026-what-our-community-made-possible/ 2026-02-24T00:00:00+00:00 https://cureangelman.org/news/celebrating-dr-david-segal-a-leader-in-science-and-a-champion-for-angelman-syndrome-research/ 2026-02-25T00:00:00+00:00 https://cureangelman.org/news/measuring-communication-in-angelman-syndrome-to-support-better-trials/ 2026-03-10T00:00:00+00:00 https://cureangelman.org/news/fast-poland-hosts-second-nationwide-conference-from-diagnosis-to-therapy/ 2026-03-20T00:00:00+00:00 https://cureangelman.org/news/important-update-on-alogabat-an-investigational-therapy-in-development-for-angelman-syndrome/ 2026-03-30T00:00:00+00:00 https://cureangelman.org/news/career-development-awards-expand-the-next-wave-of-angelman-syndrome-research/ 2026-04-02T00:00:00+00:00 https://cureangelman.org/news/fasts-action-council-member-joe-dorazio-shares-his-story-with-cnbc-cures/ 2026-04-03T00:00:00+00:00 https://cureangelman.org/news/first-patient-dosed-in-pivotal-phase-3-reveal-clinical-study-of-ion582-in-angelman-syndrome/ 2026-09-30T14:55:44+00:00 https://cureangelman.org/news/mavrix-bio-announces-fda-clearance-of-ind-application-to-initiate-first-in-human-study-of-gene-therapy-for-angelman-syndrome/ 2026-09-30T14:55:48+00:00 https://cureangelman.org/news/oak-hill-bio-to-continue-the-development-of-rugonersen-an-investigational-aso-previously-owned-by-roche/ 2026-09-30T14:55:51+00:00 https://cureangelman.org/news/community-update-new-insights-into-health-and-prevention-in-angelman-syndrome/ 2026-09-30T14:55:55+00:00 https://cureangelman.org/news/fast-spain-awards-first-research-grant/ 2026-09-30T14:55:59+00:00 https://cureangelman.org/news/ionis-pharmaceuticals-releases-information-on-their-planned-phase-3-clinical-trial-for-angelman-syndrome/ 2026-09-30T14:56:02+00:00 https://cureangelman.org/news/update-on-champion-phase-3-clinical-trial-of-ion582-obudanersen/ 2026-10-20T20:46:57+00:00 https://cureangelman.org/news/ultragenyx-announces-phase-3-aspire-results-in-angelman-syndrome/ 2026-10-20T20:46:57+00:00 https://cureangelman.org/news/rugonersen-development-update-first-participant-dosed-in-the-phase-3-beacon-trial/ 2026-10-20T20:46:59+00:00 https://cureangelman.org/news/fast-brings-angelman-syndrome-community-perspective-to-fda-rare-disease-roundtable/ 2026-10-20T20:47:03+00:00 https://cureangelman.org/news/fast-at-asgct-2026/ 2026-10-20T20:47:06+00:00 https://cureangelman.org/news/new-fast-trac-grant-collaboration-with-dr-alvin-huang/ 2026-10-22T10:32:39+00:00 https://cureangelman.org/news/neuren-pharmaceuticals-announced-top-line-results-from-its-phase-2-clinical-trial-of-nnz-2591-in-children-with-angelman-syndrome-as/ 2026-10-22T10:49:03+00:00 https://cureangelman.org/news/ionis-pharmaceuticals-a-letter-to-the-angelman-syndrome-community/ 2026-10-22T11:43:48+00:00 https://cureangelman.org/news/ionis-completes-enrollment-in-pivotal-cohort-of-the-phase-3-reveal-study-evaluating-obudanersen-in-angelman-syndrome/ 2026-10-22T11:44:47+00:00 https://cureangelman.org/news/an-update-on-the-ion582-clinical-development-program-including-halos-reveal-and-champion-trials/ 2026-10-22T11:45:50+00:00 https://cureangelman.org/news/ionis-announces-positive-detailed-results-from-the-halos-study-of-ion582-in-people-with-angelman-syndrome/ 2026-10-22T11:49:15+00:00 https://cureangelman.org/news/ionis-announces-positive-topline-results-from-phase-1-2a-trial-of-ion582-for-angelman-syndrome/ 2026-10-22T11:51:43+00:00 https://cureangelman.org/news/ultragenyx-community-update-october-2024/ 2026-10-22T12:11:38+00:00 https://cureangelman.org/news/ultragenyx-announces-successful-end-of-phase-2-meeting-with-fda-for-gtx-102-angelman-syndrome-program/ 2026-10-22T12:12:46+00:00 https://cureangelman.org/news/ultragenyx-announces-positive-interim-phase-1-2-data-in-patients-with-angelman-syndrome-after-treatment-with-gtx-102/ 2026-10-22T12:18:20+00:00 https://cureangelman.org/news/ultragenyx-shares-that-gtx-102-trials-will-officially-close-on-oct-30-2026/ 2026-10-22T12:21:24+00:00 https://cureangelman.org/news/ultragenyx-pharmaceutical-ultragenyx-announces-completion-of-enrollment-in-global-phase-1-2-trial-of-gtx-102/ 2026-10-22T12:23:42+00:00 https://cureangelman.org/news/mavrix-bio-announces-fda-rare-pediatric-disease-designation-for-investigational-mvx-220-for-the-treatment-of-angelman-syndrome/ 2026-10-22T12:39:40+00:00 https://cureangelman.org/news/mavrix-bio-announces-first-patient-dosed-in-ascend-as-trial-of-mvx-220-investigational-gene-therapy-for-angelman-syndrome/ 2026-10-22T12:40:38+00:00 https://cureangelman.org/news/mavrix-bio-receives-fda-fast-track-designation-for-mvx-220-for-treatment-of-angelman-syndrome/ 2026-10-22T12:41:56+00:00 https://cureangelman.org/news/to-further-advance-gene-therapy-research-industry-pioneer-jim-wilson-is-forming-two-independent-companies-dedicated-to-genetic-medicine/ 2026-10-22T12:44:09+00:00 https://cureangelman.org/news/fast-to-advance-gene-therapy-candidate-through-ind-enabling-studies-conducted-in-partnership-with-the-university-of-pennsylvania/ 2026-10-22T12:45:18+00:00 https://cureangelman.org/news/exciting-news-from-upenn/ 2026-10-22T12:46:41+00:00 https://cureangelman.org/news/a-new-publication-represents-a-possible-small-molecule-approach-to-potentially-treat-the-synaptic-dysfunction-observed-in-angelman-syndrome/ 2026-10-22T13:30:03+00:00 https://cureangelman.org/news/fast-announces-the-launch-of-two-biotech-companies-to-advance-investigational-gene-targeted-therapies-for-angelman-syndrome/ 2026-10-22T13:35:03+00:00 https://cureangelman.org/news/nih-grant-2023/ 2026-10-22T13:37:04+00:00 https://cureangelman.org/news/oak-hill-bio-a-message-to-the-angelman-syndrome-community/ 2026-10-22T13:42:16+00:00 https://cureangelman.org/news/an-update-on-roches-trials-of-rugonersen-ro7248824-in-angelman-syndrome/ 2026-10-22T13:45:10+00:00 https://cureangelman.org/news/update-on-rugonersen-development-and-planned-phase-3-study-beacon/ 2026-10-22T13:47:24+00:00 https://cureangelman.org/news/skylark-bio-expands-pipeline-with-first-cns-development-program-sky-as-targeting-ube3a-restoration-in-angelman-syndrome/ 2026-10-25T17:32:20+00:00 https://cureangelman.org/news/foundation-for-angelman-syndrome-therapeutics-announces-agreement-with-apertura-gene-therapy-for-access-to-blood-brain-barrier-crossing-capsid/ 2026-10-25T17:33:16+00:00 https://cureangelman.org/news/nobel-laureate-frances-arnold-brings-directed-evolution-to-angelman-syndrome-research/ 2026-10-25T17:33:43+00:00 https://cureangelman.org/news/non-viral-delivery-gene-editing-takes-an-important-step-forward-for-angelman-syndrome/ 2026-10-25T17:34:17+00:00 https://cureangelman.org/news/using-vocalization-testing-to-improve-detection-of-treatment-effects-in-angelman-syndrome-models/ 2026-10-25T17:34:59+00:00 https://cureangelman.org/news/beyond-ube3a-new-conversations-about-genotype-variants-and-future-treatments/ 2026-10-25T17:41:27+00:00 https://cureangelman.org/news/oct-8-2026-ultragenyx-community-webinar/ 2026-10-25T17:44:24+00:00 https://cureangelman.org/news/gtx-102-phase-3-results-what-we-know-what-were-still-learning-and-next-steps/ 2026-10-25T17:50:42+00:00 https://cureangelman.org/news/a-home-court-for-hope-drexel-womens-basketball-champions-angelman-syndrome-awareness/ 2026-10-25T17:55:01+00:00 https://cureangelman.org/news/fast-germanys-wachgekusst-campaign/ 2026-10-25T18:01:02+00:00 https://cureangelman.org/news/the-spark-that-brought-a-community-together/ 2026-10-25T18:02:47+00:00 https://cureangelman.org/news/spring-advocacy-update-educating-advocating-and-building-momentum/ 2026-10-25T18:09:13+00:00 https://cureangelman.org/news/2026-congressional-advocacy-day-recap-and-successes/ 2026-10-25T18:09:19+00:00 https://cureangelman.org/news/hope-in-action-angelman-community-delivers-big-wins-in-fy26-fund-bill/ 2026-10-25T18:09:24+00:00 https://cureangelman.org/news/fast-coo-ryan-fischer-named-2026-co-chair-of-everylife-community-congress/ 2026-10-25T18:09:36+00:00 https://cureangelman.org/news/join-us-on-capitol-hill-advocate-for-angelman-syndrome-research-and-awareness/ 2026-10-25T18:09:40+00:00 https://cureangelman.org/news/call-on-congress-to-enact-the-fy2026-defense-appropriations-act/ 2026-10-25T18:09:45+00:00 https://cureangelman.org/news/progress-for-angelman-syndrome-relies-on-a-strong-nih-and-fda/ 2026-10-25T18:09:51+00:00 https://cureangelman.org/news/for-jack-sonia-and-jose-take-on-the-inca-trail/ 2026-10-25T18:10:20+00:00 https://cureangelman.org/news/from-backyard-cornhole-to-big-impact-for-the-love-of-linc/ 2026-10-25T18:10:26+00:00 https://cureangelman.org/news/charlies-angels-chari-tee-golf-tournament-a-day-of-hope-community-and-action/ 2026-10-25T18:10:31+00:00 https://cureangelman.org/news/the-lamuras-organized-rally-for-a-cure-a-tennis-themed-event-that-brought-together-their-community/ 2026-10-25T18:10:41+00:00 https://cureangelman.org/news/dream-big-one-familys-journey-from-the-altar-to-the-start-line/ 2026-10-25T18:10:53+00:00 https://cureangelman.org/news/46-days-14-states-2725-miles-one-reason-briar/ 2026-10-25T18:10:59+00:00 https://cureangelman.org/news/a-sister-led-sip-shop-turns-jewelry-into-support-for-fast/ 2026-10-25T18:11:10+00:00 https://cureangelman.org/news/international-angelman-day-bash-starting-small-showing-up-big/ 2026-10-25T18:11:15+00:00 https://cureangelman.org/news/introducing-team-kick-as-a-new-way-to-rally-the-angelman-syndrome-community-through-running/ 2026-10-25T18:11:25+00:00 https://cureangelman.org/news/how-heaths-heroes-keep-turning-a-day-on-the-course-into-research-progress/ 2026-10-25T18:11:34+00:00 https://cureangelman.org/news/how-one-night-of-paddle-is-powering-angelman-syndrome-research/ 2026-10-25T18:12:04+00:00 https://cureangelman.org/news/trips-for-tripp-a-one-of-a-kind-fundraiser-with-a-clear-goal/ 2026-10-25T18:12:17+00:00 https://cureangelman.org/news/remi-cup-driving-for-a-cure-to-angelman-syndrome/ 2026-10-25T18:12:28+00:00 https://cureangelman.org/news/rewind-press-play-kick-as-a-party-with-a-bigger-purpose/ 2026-10-25T18:12:33+00:00 https://cureangelman.org/news/can-spotlight-rayes-birthday-fundraiser/ 2026-10-25T18:12:44+00:00 https://cureangelman.org/news/can-spotlight-paddle-party-for-a-purpose/ 2026-10-25T18:12:48+00:00 https://cureangelman.org/news/can-spotlight-2nd-annual-hole-out-fore-heath-golf-tournament/ 2026-10-25T18:12:54+00:00 https://cureangelman.org/news/can-spotlight-remi-cup-2024/ 2026-10-25T18:13:01+00:00 https://cureangelman.org/news/if-will-can-we-can-a-familys-vision-to-kickas-in-minneapolis/ 2026-10-25T18:13:54+00:00 https://cureangelman.org/news/how-harpers-hope-golf-tournament-has-raised-over-350000-for-angelman-syndrome-research/ 2026-10-25T18:14:00+00:00 https://cureangelman.org/news/maddies-mission-hits-1m-raised-for-angelman-syndrome/ 2026-10-25T18:14:08+00:00 https://cureangelman.org/news/granville-angels-foundation-bringing-families-together-for-angelman-syndrome/ 2026-10-25T18:14:13+00:00 https://cureangelman.org/news/joe-bologna-charity-golf-outing-raises-36000-for-sutton-strong-and-angelman-syndrome-research/ 2026-10-25T18:14:19+00:00 https://cureangelman.org/news/the-jack-packs-207-miles-of-hope/ 2026-10-25T18:14:25+00:00 https://cureangelman.org/news/fast-global-cure-angelman-now-fundraising-efforts/ 2026-10-25T18:14:31+00:00 https://cureangelman.org/news/can-spotlight-payslies-pals-cornhole-tournament-brings-community-together-for-fast-research/ 2026-10-25T18:14:37+00:00 https://cureangelman.org/news/can-spotlight-honoring-hendu-with-hope-and-research-the-always-having-fun-foundations-golf-classic/ 2026-10-25T18:14:42+00:00 https://cureangelman.org/news/can-spotlight-skating-angels-charity-ice-hockey-tournament/ 2026-10-25T18:14:48+00:00 https://cureangelman.org/news/can-spotlight-kettlebells-for-kayleigh-fundraiser-in-germany/ 2026-10-25T18:14:54+00:00 https://cureangelman.org/news/can-spotlight-bike-4-briar-starts-may-27th/ 2026-10-25T18:15:00+00:00 https://cureangelman.org/news/can-spotlight-matthew-gocker-continues-to-support-as-family-in-wisconsin/ 2026-10-25T18:15:06+00:00 https://cureangelman.org/news/introducing-the-angelman-syndrome-global-community-advisory-board-cab/ 2026-10-25T18:16:42+00:00 https://cureangelman.org/news/2025-as-congressional-advocacy-day-legislative-priorities/ 2026-10-25T18:16:51+00:00 https://cureangelman.org/news/february-2025-advocacy-updates-and-actions-to-take/ 2026-10-25T18:16:59+00:00 https://cureangelman.org/news/update-on-advocacy-efforts-and-ways-to-get-involved-in-2025/ 2026-10-25T18:17:11+00:00 https://cureangelman.org/news/the-pfdd-survey-is-now-open/ 2026-10-25T18:17:17+00:00 https://cureangelman.org/news/fast-latam-brings-families-and-research-together-in-mexico-city/ 2026-10-25T18:18:42+00:00 https://cureangelman.org/news/fast-speaks-at-the-2025-mena-congress-for-rare-diseases/ 2026-10-25T18:18:52+00:00 https://cureangelman.org/news/fast-poland-organized-the-1st-polish-national-angelman-syndrome-conference/ 2026-10-25T18:19:09+00:00 https://cureangelman.org/news/fast-italy-hosts-its-first-scientific-symposium-on-angelman-syndrome/ 2026-10-25T18:19:16+00:00 https://cureangelman.org/news/turning-possibility-into-progress-the-rush-f-a-s-t-center-for-translational-research-opens-in-chicago/ 2026-10-25T18:19:50+00:00